Yoon SE - Search Results

1

Immune checkpoint inhibitors in patients with pretreated HodgkinÊs lymphoma: a Korean single-center, retrospective study.

Hur JY, Yoon SE, Kim SJ, Kim WS. Hur JY, et al. Among authors: yoon se. Blood Res. 2020 Jun 30;55(2):85-90. doi: 10.5045/br.2020.2020014. Blood Res. 2020. PMID: 32595170 Free PMC article.

2

Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review.

Kim SJ, Yoon SE, Kim WS. Kim SJ, et al. Among authors: yoon se. J Hematol Oncol. 2018 Dec 20;11(1):140. doi: 10.1186/s13045-018-0687-0. J Hematol Oncol. 2018. PMID: 30567593 Free PMC article.

3

Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression.

Cho J, Kim SJ, Park WY, Kim J, Woo J, Kim G, Yoon SE, Ko YH, Kim WS. Cho J, et al. Among authors: yoon se. Mod Pathol. 2020 Apr;33(4):603-615. doi: 10.1038/s41379-019-0392-8. Epub 2019 Oct 25. Mod Pathol. 2020. PMID: 31653980 Free article.

4

Impact of fear of cancer recurrence on survival among lymphoma patients.

Kim SJ, Kang D, Kim IR, Yoon SE, Kim WS, Butow PN, Guallar E, Cho J. Kim SJ, et al. Among authors: yoon se. Psychooncology. 2020 Feb;29(2):364-372. doi: 10.1002/pon.5265. Epub 2020 Jan 6. Psychooncology. 2020. PMID: 31654534

5

Asian variant of intravascular large B-cell lymphoma: a comparison of clinical features based on involvement of the central nervous system.

Yoon SE, Kim WS, Kim SJ. Yoon SE, et al. Korean J Intern Med. 2020 Jul;35(4):946-956. doi: 10.3904/kjim.2018.396. Epub 2019 Nov 25. Korean J Intern Med. 2020. PMID: 31752477 Free PMC article.

6

Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis.

Hong JY, Yoon DH, Yoon SE, Kim SJ, Lee HS, Eom HS, Lee HW, Shin DY, Koh Y, Yoon SS, Jo JC, Kim JS, Kim SJ, Cho SH, Lee WS, Won JH, Kim WS, Suh C. Hong JY, et al. Among authors: yoon ss, yoon dh, yoon se. Sci Rep. 2019 Dec 30;9(1):20302. doi: 10.1038/s41598-019-56891-0. Sci Rep. 2019. PMID: 31889144 Free PMC article.

7

Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma.

Cho I, Lee H, Yoon SE, Ryu KJ, Ko YH, Kim WS, Kim SJ. Cho I, et al. Among authors: yoon se. BMC Cancer. 2020 Feb 13;20(1):120. doi: 10.1186/s12885-020-6612-2. BMC Cancer. 2020. PMID: 32054467 Free PMC article.

8

Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.

Yi JH, Yoon SE, Ryu KJ, Ko YH, Kim WS, Kim SJ. Yi JH, et al. Among authors: yoon se. Cytokine. 2020 May;129:155048. doi: 10.1016/j.cyto.2020.155048. Epub 2020 Mar 2. Cytokine. 2020. PMID: 32135464

9

Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas.

Hur JY, Kim YJ, Yoon SE, Son DS, Park WY, Kim SJ, Park D, Kim WS. Hur JY, et al. Among authors: yoon se. Ann Hematol. 2020 Jun;99(6):1293-1302. doi: 10.1007/s00277-020-04008-3. Epub 2020 Apr 15. Ann Hematol. 2020. PMID: 32296914

10

A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.

Yoon SE, Kim SJ, Yoon DH, Koh Y, Mun YC, Do YR, Choi YS, Yang DH, Kim MK, Lee GW, Suh C, Ko YH, Kim WS. Yoon SE, et al. Among authors: yoon dh. Ann Hematol. 2020 Jun;99(6):1283-1291. doi: 10.1007/s00277-020-04005-6. Epub 2020 Apr 24. Ann Hematol. 2020. PMID: 32333154 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page